Cited by 153Fatty Acid Research and HealthAquaculture Nutrition and GrowthEdible Oils Quality and Analysis

Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background.

Open access
Conquer, Julie A., Holub, Bruce J.·1998·Journal of Lipid Research

Abstract

There is evidence to indicate that the high rates of coronary heart disease and myocardial infarction amongst Indians of Asian descent may be partly related to circulating nonesterified fatty acids (NEFA). As docosahexaenoic acid (DHA,22:6n-3) in NEFA form has been found to exhibit anti-platelet aggregatory and anti-arrhythmic potential in vitro, the effect of supplementary DHA was examined in healthy subjects of Asian Indian background. Furthermore, time- and dose-dependent changes in absolute levels of DHA as NEFA or phospholipid (PL) were compared. The subjects consumed 8 capsules daily of placebo (DHA-free) or low DHA (0.75 g/day)or high DHA (1.50 g/day) over 6 wks. Fasting blood samples were drawn at days 0, 21, and 42 for analysis of serum lipid/lipoprotein composition. No significant effect of DHA supplementation on the levels of serum lipid/lipoproteins (including Lp[a]) or blood pressure was found. However, the DHA level in serum phospholipid rose by 167% overall with low-dose supplementation (from 2.4-6.4 mol%) but only by an additional 23% upon doubling the dose from 0.75 g to 1.50 g/day. Furthermore, after 6 weeks of supplementation with 0.75 g or 1.5 g DHA/day, absolute concentrations of DHA as PL were not significantly different from the corresponding 3-week values. Interestingly, the absolute concentrations of serum DHA as NEFA showed a marked rise with low-dose supplementation (by 212% overall, from 2.4 to 7.5 microM) and a further 70% rise (to 12.7 microM) upon doubling the supplementation from 0.75 to 1.50 g/day. As well, the 6-week concentrations (DHA-NEFA) were significantly different than the corresponding 3-week values at both dose levels. Elevation of circulating DHA-NEFA levels via DHA supplementation, as shown herein, to concentrations that exhibit anti-thrombotic and anti-arrhythmic potential in vitro needs to be extended to trials where clinical end-points are determined.

Integrity signals

Registry

Crossref · 10.1016/s0022-2275(20)33890-6

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Conquer, J. A., & Holub, B. J.
Affiliations
University of Guelph (CA)
Corresponding author
Holub, Bruce J.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
1998-02
Volume
39
Issue
2
Pages
286-292
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2186252941
Cited by
153
References
32
Citations by year
2025: 5 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 7 · 2020: 3 · 2019: 9 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 9 · 2014: 8 · 2013: 2 · 2012: 10
FWCI
4.65
Type
journal article
Language
en
Open access
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
  • Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
Keywords
docosahexaenoic acid, DHA supplementation, free fatty acids, omega-3 fatty acids, dose-dependent effects, serum phospholipids, serum lipids, lipoproteins, Asian Indian population, coronary artery disease, anti-thrombotic effects, antiarrhythmic effect, blood pressure
MeSH terms
Arrhythmias, Cardiac, Blood Pressure, Docosahexaenoic Acids, Dose-Response Relationship, Drug, Fatty Acids, Nonesterified, Female, Heart Rate, Humans, India, Kinetics, Male, Ontario, Phospholipids, Thrombosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review